dilazep has been researched along with Behcet Syndrome in 1 studies
Dilazep: Coronary vasodilator with some antiarrhythmic activity.
dilazep : A member of the class of diazepanes that is 1,4-diazepane substituted by 3-[(3,4,5-trimethoxybenzoyl)oxy]propyl groups at positions 1 and 4. It is a potent adenosine uptake inhibitor that exhibits antiplatelet, antianginal and vasodilator properties.
Behcet Syndrome: Rare chronic inflammatory disease involving the small blood vessels. It is of unknown etiology and characterized by mucocutaneous ulceration in the mouth and genital region and uveitis with hypopyon. The neuro-ocular form may cause blindness and death. SYNOVITIS; THROMBOPHLEBITIS; gastrointestinal ulcerations; RETINAL VASCULITIS; and OPTIC ATROPHY may occur as well.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Immunofluorescence study revealed IgA nephropathy." | 1.35 | Behçet's disease complicated by IgA nephropathy with nephrotic syndrome. ( Hashimoto, T; Inayama, Y; Iwatsubo, K; Kihara, M; Kokuho, T; Kuji, T; Oshikawa, J; Tamura, K; Tanaka, K; Toya, Y; Umemura, S; Yabana, M; Yanagi, M; Yoshida, S, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hashimoto, T | 1 |
| Toya, Y | 1 |
| Kihara, M | 1 |
| Yabana, M | 1 |
| Inayama, Y | 1 |
| Tanaka, K | 1 |
| Iwatsubo, K | 1 |
| Yanagi, M | 1 |
| Oshikawa, J | 1 |
| Kokuho, T | 1 |
| Kuji, T | 1 |
| Yoshida, S | 1 |
| Tamura, K | 1 |
| Umemura, S | 1 |
1 other study available for dilazep and Behcet Syndrome
| Article | Year |
|---|---|
Behçet's disease complicated by IgA nephropathy with nephrotic syndrome.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Atorvastatin; Behcet Syndrome; Benzimidazoles; Biphen | 2008 |